{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:21:16Z","timestamp":1784733676917,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was funded by the Scientific Research Projects Coordination Unit of Istanbul University","award":["Grant number: TDK-2019-35336."],"award-info":[{"award-number":["Grant number: TDK-2019-35336."]}]},{"name":"This study was funded by the Scientific Research Projects Coordination Unit of Istanbul University","award":["Grant number: TDK-2019-35336."],"award-info":[{"award-number":["Grant number: TDK-2019-35336."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The identification of novel non-invasive biomarkers is imperative for the early diagnosis and monitoring of malignant melanoma. The objective of this study is to examine the expression levels of miR-155-5p, miR-181b-5p, and miR-454-3p in circulating cell-free RNA obtained from plasma samples of the 72 uveal malignant melanoma patients and to compare these levels with those of 72 healthy controls. The analysis showed that the expression level of the miR-181b-5p has increased 9.25 fold, and expression level of miR-155-5p has increased 6.67 fold, and miR-454-3p expression level has increased 4.14 fold in the patient group compared with the levels in the healthy control group (p\u2009=\u20090.005). It was found that the high expression levels of the three miRNAs were statistically significant in patients compared with in the healthy control group. The statistical evaluations between miRNA expression levels and clinical data showed that miR-155-5p had significant association with radiation therapy (p\u2009=\u20090.040), and miR-454-3p showed a significant association with smoking and alcohol use respectively (p\u2009=\u20090.009, and p\u2009=\u20090.026). The significantly elevated expression levels of miR-181b-5p, miR-155-5p, and miR-454-3p in the circulating cell-free RNA of plasma from uveal melanoma patients, in comparison to those in the healthy control group, suggest the potential usefulness of these biomarkers for both early diagnosis and disease monitoring. However, more extensive and future studies are needed to use these molecules in early diagnosis and disease monitoring.<\/jats:p>","DOI":"10.1007\/s10528-024-10849-8","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:57:49Z","timestamp":1719244669000},"page":"3187-3205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring of miR-155-5p, miR-181b-5p, and miR-454-3p Expressions in Circulating Cell-Free RNA: Insights from Peripheral Blood of Uveal Malignant Melanoma Patients"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8976-4450","authenticated-orcid":false,"given":"Hassani","family":"Masoumeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-7360","authenticated-orcid":false,"given":"Do\u011fan","family":"Tunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-8481","authenticated-orcid":false,"given":"\u00d6demi\u015f Akdeniz","family":"Demet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-8613","authenticated-orcid":false,"given":"Tuncer","family":"Samuray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-0482","authenticated-orcid":false,"given":"Yaz\u0131c\u0131","family":"H\u00fclya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"16","key":"10849_CR1","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.3390\/ijms21165648","volume":"21","author":"K Aughton","year":"2020","unstructured":"Aughton K, Kalirai H, Coupland SE (2020) MicroRNAs and uveal melanoma: understanding the diverse role of these small molecular regulators. Int J Mol Sci 21(16):5648","journal-title":"Int J Mol Sci"},{"issue":"42","key":"10849_CR2","doi-asserted-by":"publisher","first-page":"26188","DOI":"10.1074\/jbc.272.42.26188","volume":"272","author":"JP Basuyaux","year":"1997","unstructured":"Basuyaux JP et al (1997) The Ets transcription factors interact with each other and with the c-Fos\/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem 272(42):26188\u201326195","journal-title":"J Biol Chem"},{"issue":"12","key":"10849_CR3","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/jcmm.12927","volume":"20","author":"E Bignotti","year":"2016","unstructured":"Bignotti E et al (2016) Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues. J Cell Mol Med 20(12):2341\u20132348","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10849_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/107327480401100505","volume":"11","author":"S Brownstein","year":"2004","unstructured":"Brownstein S (2004) Malignant melanoma of the conjunctiva. Cancer Control 11(5):310\u2013316","journal-title":"Cancer Control"},{"issue":"23","key":"10849_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2014.6096","volume":"311","author":"RD Carvajal","year":"2014","unstructured":"Carvajal RD et al (2014) Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA 311(23):2397\u20132405","journal-title":"JAMA"},{"issue":"10","key":"10849_CR6","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G (2016) MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci 17(10):1712","journal-title":"Int J Mol Sci"},{"issue":"27","key":"10849_CR7","doi-asserted-by":"publisher","first-page":"42683","DOI":"10.18632\/oncotarget.7977","volume":"7","author":"C Chakraborty","year":"2016","unstructured":"Chakraborty C et al (2016) MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia. Oncotarget 7(27):42683\u201342697","journal-title":"Oncotarget"},{"issue":"8","key":"10849_CR8","first-page":"1664","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR (1998) The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. American Coll Surg Comm Cancer American Cancer Soc Cancer 83(8):1664\u20131678","journal-title":"American Coll Surg Comm Cancer American Cancer Soc Cancer"},{"issue":"10","key":"10849_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997\u20131006","journal-title":"Cell Res"},{"issue":"3","key":"10849_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1167\/iovs.10-5272","volume":"52","author":"X Chen","year":"2011","unstructured":"Chen X et al (2011) Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol vis Sci 52(3):1193\u20131199","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"7","key":"10849_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI0215418","volume":"109","author":"A Danilkovitch-Miagkova","year":"2002","unstructured":"Danilkovitch-Miagkova A, Zbar B (2002) Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109(7):863\u2013867","journal-title":"J Clin Invest"},{"issue":"1","key":"10849_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00006982-200001000-00014","volume":"20","author":"S Dithmar","year":"2000","unstructured":"Dithmar S, Diaz CE, Grossniklaus HE (2000) Intraocular melanoma spread to regional lymph nodes: report of two cases. Retina 20(1):76\u201379","journal-title":"Retina"},{"issue":"2","key":"10849_CR13","first-page":"186","volume":"6","author":"M Dogrusoz","year":"2017","unstructured":"Dogrusoz M, Jager MJ, Damato B (2017) Uveal melanoma treatment and prognostication. Asia Pac J Ophthalmol (phila) 6(2):186\u2013196","journal-title":"Asia Pac J Ophthalmol (phila)"},{"issue":"8","key":"10849_CR14","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1210\/me.2015-1080","volume":"29","author":"VK Eedunuri","year":"2015","unstructured":"Eedunuri VK et al (2015) miR-137 targets p160 steroid receptor coactivators SRC1, SRC2, and SRC3 and inhibits cell proliferation. Mol Endocrinol 29(8):1170\u20131183","journal-title":"Mol Endocrinol"},{"issue":"24","key":"10849_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.4161\/cbt.8.24.10765","volume":"8","author":"AE Erson","year":"2009","unstructured":"Erson AE, Petty EM (2009) miRNAs and cancer: new research developments and potential clinical applications. Cancer Biol Ther 8(24):2317\u20132322","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"10849_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","volume":"107","author":"S Eskelin","year":"2000","unstructured":"Eskelin S et al (2000) Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 107(8):1443\u20131449","journal-title":"Ophthalmology"},{"issue":"4","key":"10849_CR17","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/cancers7040904","volume":"7","author":"T Frixa","year":"2015","unstructured":"Frixa T, Donzelli S, Blandino G (2015) Oncogenic MicroRNAs: key players in malignant transformation. Cancers (basel) 7(4):2466\u20132485","journal-title":"Cancers (basel)"},{"issue":"4","key":"10849_CR18","first-page":"60","volume":"8","author":"G Gattuso","year":"2022","unstructured":"Gattuso G et al (2022) Liquid biopsy and circulating biomarkers for the diagnosis of precancerous and cancerous oral lesions. Noncoding RNA 8(4):60","journal-title":"Noncoding RNA"},{"issue":"1","key":"10849_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10555-007-9107-6","volume":"27","author":"A Gentile","year":"2008","unstructured":"Gentile A, Trusolino L, Comoglio PM (2008) The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 27(1):85\u201394","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"10849_CR20","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S et al (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3(9):e3148","journal-title":"PLoS ONE"},{"issue":"7","key":"10849_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522\u2013531","journal-title":"Nat Rev Genet"},{"issue":"14","key":"10849_CR22","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B et al (2020) miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 16(14):2628\u20132647","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10849_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ et al (2020) Uveal Melanoma. Nat Rev Dis Primers 6(1):24","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10849_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000508613","volume":"7","author":"E Jin","year":"2021","unstructured":"Jin E, Burnier JV (2021) Liquid biopsy in uveal melanoma: are we there yet? Ocul Oncol Pathol 7(1):1\u201316","journal-title":"Ocul Oncol Pathol"},{"issue":"11","key":"10849_CR25","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/ijc.24984","volume":"126","author":"CC Johansson","year":"2010","unstructured":"Johansson CC et al (2010) Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer 126(11):2682\u20132689","journal-title":"Int J Cancer"},{"issue":"6","key":"10849_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.molcel.2004.05.027","volume":"14","author":"MW Jones-Rhoades","year":"2004","unstructured":"Jones-Rhoades MW, Bartel DP (2004) Computational identification of plant microRNAs and their targets, including a stress-induced miRNA. Mol Cell 14(6):787\u2013799","journal-title":"Mol Cell"},{"issue":"6","key":"10849_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4274\/tjo.galenos.2020.22567","volume":"50","author":"I Koc","year":"2020","unstructured":"Koc I, Kiratli H (2020) Current management of conjunctival melanoma part 2: treatment and future directions. Turk J Ophthalmol 50(6):362\u2013370","journal-title":"Turk J Ophthalmol"},{"key":"10849_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","volume":"11","author":"BA Krantz","year":"2017","unstructured":"Krantz BA et al (2017) Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol 11:279\u2013289","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10849_CR29","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivela T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol vis Sci 44(11):4651\u20134659","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10849_CR30","doi-asserted-by":"publisher","first-page":"e11166","DOI":"10.1371\/journal.pone.0011166","volume":"5","author":"A Lagana","year":"2010","unstructured":"Lagana A et al (2010) Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLoS ONE 5(6):e11166","journal-title":"PLoS ONE"},{"issue":"10","key":"10849_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/sj.bjc.6603381","volume":"95","author":"P Lamy","year":"2006","unstructured":"Lamy P et al (2006) Are microRNAs located in genomic regions associated with cancer? Br J Cancer 95(10):1415\u20131418","journal-title":"Br J Cancer"},{"issue":"8","key":"10849_CR32","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3760\/cma.j.issn.0366-6999.20133206","volume":"127","author":"Y Li","year":"2014","unstructured":"Li Y et al (2014) MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1. Chin Med J (engl) 127(8):1410\u20131416","journal-title":"Chin Med J (engl)"},{"issue":"7","key":"10849_CR33","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.18632\/oncotarget.2923","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z et al (2015) MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget 6(7):4562\u20134568","journal-title":"Oncotarget"},{"key":"10849_CR34","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2147\/CMAR.S196655","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019) High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma. Cancer Manag Res 11:2795\u20132802","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10849_CR35","doi-asserted-by":"publisher","first-page":"12412","DOI":"10.1002\/jcb.28507","volume":"120","author":"J Li","year":"2019","unstructured":"Li J et al (2019) miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3\/AKT3 in uveal melanoma. J Cell Biochem 120(8):12412\u201312421","journal-title":"J Cell Biochem"},{"key":"10849_CR36","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.2147\/OTT.S253946","volume":"13","author":"YF Li","year":"2020","unstructured":"Li YF et al (2020) A review of MicroRNA in Uveal melanoma. Onco Targets Ther 13:6351\u20136359","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10849_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4238\/gmr16039067","volume":"16","author":"JW Ling","year":"2017","unstructured":"Ling JW et al (2017) miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN. Genet Mol Res 16(3):10\u20134238","journal-title":"Genet Mol Res"},{"issue":"18","key":"10849_CR38","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1080\/15287394.2012.699856","volume":"75","author":"R Liu","year":"2012","unstructured":"Liu R et al (2012) Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A 75(18):1154\u20131162","journal-title":"J Toxicol Environ Health A"},{"issue":"1","key":"10849_CR39","first-page":"46","volume":"25","author":"J Liu","year":"2013","unstructured":"Liu J et al (2013) Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 25(1):46\u201354","journal-title":"Chin J Cancer Res"},{"key":"10849_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fcell.2020.00023","volume":"8","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) Crosstalk mechanisms between HGF\/c-Met Axis and ncRNAs in malignancy. Front Cell Dev Biol 8:23","journal-title":"Front Cell Dev Biol"},{"issue":"20","key":"10849_CR41","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1002\/cncr.28282","volume":"119","author":"JJ Luke","year":"2013","unstructured":"Luke JJ et al (2013) Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the dana-farber cancer institute, massachusetts general hospital, memorial sloan-kettering cancer center, and university hospital of lausanne experience. Cancer 119(20):3687\u20133695","journal-title":"Cancer"},{"issue":"4","key":"10849_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.currproblcancer.2011.07.004","volume":"35","author":"MA Materin","year":"2011","unstructured":"Materin MA, Faries M, Kluger HM (2011) Molecular alternations in uveal melanoma. Curr Probl Cancer 35(4):211\u2013224","journal-title":"Curr Probl Cancer"},{"issue":"5","key":"10849_CR43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC et al (2005) Incidence of noncutaneous melanomas in the US. Cancer 103(5):1000\u20131007","journal-title":"Cancer"},{"issue":"30","key":"10849_CR44","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513\u201310518","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10849_CR45","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1177\/1533034617737923","volume":"16","author":"J Peng","year":"2017","unstructured":"Peng J, Liu H, Liu C (2017) MiR-155 Promotes uveal melanoma cell proliferation and invasion by regulating NDFIP1 expression. Technol Cancer Res Treat 16(6):1160\u20131167","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10849_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7150\/thno.29055","volume":"9","author":"L Ren","year":"2019","unstructured":"Ren L et al (2019) MiR-454-3p-mediated Wnt\/beta-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics 9(2):449\u2013465","journal-title":"Theranostics"},{"issue":"4","key":"10849_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","volume":"42","author":"S Seregard","year":"1998","unstructured":"Seregard S (1998) Conjunctival melanoma. Surv Ophthalmol 42(4):321\u2013350","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10849_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10072-014-1938-7","volume":"36","author":"N Shao","year":"2015","unstructured":"Shao N et al (2015) Plasma miR-454-3p as a potential prognostic indicator in human glioma. Neurol Sci 36(2):309\u2013313","journal-title":"Neurol Sci"},{"issue":"2","key":"10849_CR49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ophtha.2014.08.046","volume":"122","author":"JA Shields","year":"2015","unstructured":"Shields JA, Shields CL (2015) Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens Lect Ophthalmol 122(2):414\u2013428","journal-title":"Schepens Lect Ophthalmol"},{"issue":"10","key":"10849_CR50","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ophtha.2013.03.012","volume":"120","author":"CL Shields","year":"2013","unstructured":"Shields CL et al (2013) American joint committee on cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients. Ophthalmology 120(10):2066\u20132071","journal-title":"Ophthalmology"},{"issue":"3","key":"10849_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00008390-200106000-00007","volume":"11","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields CL, Shields JA (2001) Prognostic factors in uveal melanoma. Melanoma Res 11(3):255\u2013263","journal-title":"Melanoma Res"},{"issue":"6","key":"10849_CR52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/cancers11060815","volume":"11","author":"KN Smit","year":"2019","unstructured":"Smit KN et al (2019) Aberrant MicroRNA expression and its implications for uveal melanoma metastasis. Cancers (basel) 11(6):815","journal-title":"Cancers (basel)"},{"key":"10849_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/1471-2407-14-448","volume":"14","author":"M Sochor","year":"2014","unstructured":"Sochor M et al (2014) Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer 14:448","journal-title":"BMC Cancer"},{"issue":"3","key":"10849_CR54","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2019.06.126","volume":"516","author":"Y Song","year":"2019","unstructured":"Song Y et al (2019) miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3. Biochem Biophys Res Commun 516(3):872\u2013879","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10849_CR55","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/cancers13164020","volume":"13","author":"Z Souri","year":"2021","unstructured":"Souri Z et al (2021) MiRNAs correlate with HLA expression in uveal melanoma: both up- and downregulation are related to monosomy 3. Cancers (basel) 13(16):4020","journal-title":"Cancers (basel)"},{"issue":"5","key":"10849_CR56","doi-asserted-by":"publisher","first-page":"e0124428","DOI":"10.1371\/journal.pone.0124428","volume":"10","author":"L Sun","year":"2015","unstructured":"Sun L et al (2015) MiR-144 inhibits uveal melanoma cell proliferation and invasion by regulating c-Met expression. PLoS ONE 10(5):e0124428","journal-title":"PLoS ONE"},{"key":"10849_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gde.2018.01.001","volume":"48","author":"I Vannini","year":"2018","unstructured":"Vannini I, Fanini F, Fabbri M (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128\u2013133","journal-title":"Curr Opin Genet Dev"},{"key":"10849_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.intimp.2016.09.004","volume":"40","author":"M Venza","year":"2016","unstructured":"Venza M et al (2016) miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells. Int Immunopharmacol 40:235\u2013243","journal-title":"Int Immunopharmacol"},{"issue":"1\u20132","key":"10849_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-017-3248-x","volume":"445","author":"X Wang","year":"2018","unstructured":"Wang X et al (2018) Coordinated targeting of MMP-2\/MMP-9 by miR-296-3p\/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma. Mol Cell Biochem 445(1\u20132):25\u201333","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"10849_CR60","first-page":"1258","volume":"11","author":"YC Wang","year":"2018","unstructured":"Wang YC et al (2018) Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein. Int J Ophthalmol 11(8):1258\u20131268","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10849_CR61","first-page":"2462","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) Role of miR-23a\/Zeb1 negative feedback loop in regulating epithelial-mesenchymal transition and tumorigenicity of intraocular tumors. Oncol Lett 16(2):2462\u20132470","journal-title":"Oncol Lett"},{"issue":"9","key":"10849_CR62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/onc.2012.128","volume":"32","author":"A Ward","year":"2013","unstructured":"Ward A et al (2013) Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32(9):1173\u20131182","journal-title":"Oncogene"},{"issue":"3","key":"10849_CR63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1586\/17469899.2014.921119","volume":"9","author":"JR Wong","year":"2014","unstructured":"Wong JR et al (2014) Management of conjunctival malignant melanoma: a review and update. Expert Rev Ophthalmol 9(3):185\u2013204","journal-title":"Expert Rev Ophthalmol"},{"key":"10849_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1748-717X-9-179","volume":"9","author":"X Wu","year":"2014","unstructured":"Wu X et al (2014) Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells. Radiat Oncol 9:179","journal-title":"Radiat Oncol"},{"issue":"4","key":"10849_CR65","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1167\/iovs.08-2681","volume":"50","author":"D Yan","year":"2009","unstructured":"Yan D et al (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol vis Sci 50(4):1559\u20131565","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10849_CR66","first-page":"4363","volume":"17","author":"H Yao","year":"2019","unstructured":"Yao H, Sun Q, Zhu J (2019) miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin. Exp Ther Med 17(6):4363\u20134370","journal-title":"Exp Ther Med"},{"issue":"1","key":"10849_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B et al (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1\u201312","journal-title":"Dev Biol"},{"issue":"1","key":"10849_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-018-0679-5","volume":"37","author":"L Zhang","year":"2018","unstructured":"Zhang L et al (2018) The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma. J Exp Clin Cancer Res 37(1):15","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10849_CR69","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.ymthe.2019.03.020","volume":"27","author":"T Zhang","year":"2019","unstructured":"Zhang T, Xue X, Peng H (2019) Therapeutic delivery of miR-29b enhances radiosensitivity in cervical cancer. Mol Ther 27(6):1183\u20131194","journal-title":"Mol Ther"},{"issue":"2","key":"10849_CR70","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3892\/mmr.2016.5433","volume":"14","author":"J Zhou","year":"2016","unstructured":"Zhou J et al (2016) Oncogenic role of microRNA-20a in human uveal melanoma. Mol Med Rep 14(2):1560\u20131566","journal-title":"Mol Med Rep"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:54:50Z","timestamp":1757109290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10849"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10849-8","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}